Cleared Traditional

Synermed ISE Reagents (K181201) - FDA 510(k) Clearance

Class II Chemistry device cleared through predicate-based substantial equivalence - typically does not require clinical trials.

K181201 · Infrared Laboratory Systems, LLC (Dba Synermed) · Chemistry device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Jul 2018
Decision
64d
Days
Class 2
Risk

K181201 is an FDA 510(k) clearance for the Synermed ISE Reagents. Classified as Electrode, Ion Specific, Sodium (product code JGS), Class II - Special Controls.

Submitted by Infrared Laboratory Systems, LLC (Dba Synermed) (Westfield, US). The FDA issued a Cleared decision on July 10, 2018 after a review of 64 days - a notably fast clearance cycle.

This device falls under the Chemistry FDA review panel, regulated under 21 CFR 862.1665 - the FDA in vitro diagnostics and chemistry framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Fast-track predicate clearance. Standard predicate reliance. The short review cycle indicates strong predicate alignment - the FDA found sufficient equivalence without extended technical review.

View all Infrared Laboratory Systems, LLC (Dba Synermed) devices

Submission Details

510(k) Number K181201 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received May 07, 2018
Decision Date July 10, 2018
Days to Decision 64 days
Submission Type Traditional
Review Panel Chemistry (CH)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
24d faster than avg
Panel avg: 88d · This submission: 64d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

Device Classification

Product Code JGS Electrode, Ion Specific, Sodium
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 862.1665
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Chemistry devices follow this clearance model.

Regulatory Peers - JGS Electrode, Ion Specific, Sodium

All 67
Devices cleared under the same product code (JGS) and FDA review panel - the closest regulatory comparables to K181201.
LIASYS 600 Electrolyte Measurement System, LIASYS 600 Creatinine reagent, LIASYS 600
K172232 · Ams Diagnostics · Jun 2019
GEM Premier ChemSTAT
K183549 · Instrumentation Laboratory CO · Feb 2019
Stat Profile Prime Plus Analyzer System
K180428 · Nova Biomedical Corporation · Aug 2018
SelectaLyte Electrolyte Analyzer (Na+, K+, Cl-)
K171476 · Awareness Technology, Inc. · Feb 2018
Atellica Solution, Atellica A-LYTE Integrated Multisensor Na+/K+/CI-, Atellica CH Albumin BCP Reagent (Alb_p), Atellica IM Thyroid Stimulating Hormone TSH, Atellica CH Vancomycin (Vanc)
K161954 · Siemens Healthcare Diagnostics · Mar 2017
ISE Reagent, Glucose, CRP Latex, DxC 700 AU Clinical Chemistry Analyzer
K161837 · Beckman Coulter, Inc. · Dec 2016